Bone morphogenetic protein 10 as a predictor for recurrent atrial fibrillation after catheter ablation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Atrial fibrillation (AF) recurrence after catheter ablation (CA) poses a major challenge. The novel atrial-specific biomarker, bone morphogenetic protein 10 (BMP10), might aid in the selection of appropriate patients for CA. PURPOS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennings, E, Aeschbacher, S, Coslovsky, M, Paladini, R E, Spies, F, Voellmin, G, Conen, D, Zuern, C S, Krisai, P, Badertscher, P, Sticherling, C, Osswald, S, Knecht, S, Kuehne, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.4.5 - Rhythm Control, Catheter Ablation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206880/
http://dx.doi.org/10.1093/europace/euad122.082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206880/
http://dx.doi.org/10.1093/europace/euad122.082

Ejemplares similares